DOSE Rapid Dose Therapeutics Corp.
Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system designed to rapidly release pharmaceuticals, emulsified oils, and over-the-counter medicines into the bloodstream. It also provides over-the-counter products consisting of QuickStrip Energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12; and QuickStrip Sleep to deliver melatonin, as well as dental products including Lidocaine QuickStrip, a muco-adhesive oral thin film. It also engages in the research, production, provision, and distribution of technical services for the delivery of oral thin film strips containing active ingredients. In addition, the company is involved in the sale of health and wellness products, such as nutraceuticals; white label manufacturing, including oral thin film strips containing active ingredients under cannabis licensing; and the provision of consulting services for the application of active ingredients with the oral thin film polymer formulation and processes. Rapid Dose Therapeutics Corp. is headquartered in Burlington, Canada.…
Industry Peers
BiotechnologyKey Statistics
About Rapid Dose Therapeutics (CNSX: DOSE)
›
Rapid Dose Therapeutics (CNSX: DOSE) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.
The shares were at 0.0950 CAD on 20 November 2026, down 42.4% over 52 weeks. Its 52-week range is 0.0800 CAD to 0.1900 CAD: the price is 50.0% below the high and 18.7% above the low.
Its market capitalisation is 13.09M CAD.
Rapid Dose Therapeutics reports return on equity of 47.2%, an operating margin of -88.5% and revenue down 67.8% year over year.
Its debt exceeds its cash by 5.87M CAD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.